Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP23985.RAlcpDf8_u9B0N1ueCliuUp6vD8RKyT3Ht3TuEzVQaC1I130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP23985.RAlcpDf8_u9B0N1ueCliuUp6vD8RKyT3Ht3TuEzVQaC1I130_assertion type Assertion NP23985.RAlcpDf8_u9B0N1ueCliuUp6vD8RKyT3Ht3TuEzVQaC1I130_head.
- NP23985.RAlcpDf8_u9B0N1ueCliuUp6vD8RKyT3Ht3TuEzVQaC1I130_assertion description "[Selective inhibition of prostaglandin E2 receptors EP2 and EP4 induces apoptosis of human endometriotic cells through suppression of ERK1/2, AKT, NFkappaB, and beta-catenin pathways and activation of intrinsic apoptotic mechanisms.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP23985.RAlcpDf8_u9B0N1ueCliuUp6vD8RKyT3Ht3TuEzVQaC1I130_provenance.
- NP23985.RAlcpDf8_u9B0N1ueCliuUp6vD8RKyT3Ht3TuEzVQaC1I130_assertion evidence source_evidence_curated NP23985.RAlcpDf8_u9B0N1ueCliuUp6vD8RKyT3Ht3TuEzVQaC1I130_provenance.
- NP23985.RAlcpDf8_u9B0N1ueCliuUp6vD8RKyT3Ht3TuEzVQaC1I130_assertion SIO_000772 19407222 NP23985.RAlcpDf8_u9B0N1ueCliuUp6vD8RKyT3Ht3TuEzVQaC1I130_provenance.
- NP23985.RAlcpDf8_u9B0N1ueCliuUp6vD8RKyT3Ht3TuEzVQaC1I130_assertion wasDerivedFrom ctd_human-2016 NP23985.RAlcpDf8_u9B0N1ueCliuUp6vD8RKyT3Ht3TuEzVQaC1I130_provenance.
- NP23985.RAlcpDf8_u9B0N1ueCliuUp6vD8RKyT3Ht3TuEzVQaC1I130_assertion wasGeneratedBy ECO_0000218 NP23985.RAlcpDf8_u9B0N1ueCliuUp6vD8RKyT3Ht3TuEzVQaC1I130_provenance.